Spectrum of Current Management of Pediatric Pulmonary Hypertensive Crisis

Meghan L Bernier1, Lewis H Romer, Melania M Bembea1

  • 1Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Insights

Pediatric pulmonary hypertensive crisis management varies widely in North American PICUs. This survey highlights diverse approaches to care, indicating a need for standardized guidelines for better outcomes.

Area of Science:

  • Pediatric Critical Care Medicine
  • Cardiology
  • Pulmonology

Background:

  • Pulmonary hypertension is an increasing concern in pediatric populations.
  • Children can experience pulmonary hypertensive crisis, a critical condition requiring immediate medical intervention.

Purpose of the Study:

  • To investigate and describe the range of treatments administered in North American Pediatric Intensive Care Units (PICUs) for children experiencing pulmonary hypertensive crisis.

Main Methods:

  • A cross-sectional electronic survey was distributed to faculty members in PICUs across the United States and Canada.
  • The survey collected data on institutional demographics, patient populations, diagnostic tools, pharmacotherapies, supportive care strategies, and multidisciplinary team structures.

Main Results:

  • The survey achieved a 50% response rate from 99 identified institutions, with most respondents being experienced pediatric intensivists.
  • Significant variability was observed in diagnostic protocols (e.g., echocardiography, cardiac catheterization indications) and therapeutic interventions, including mechanical ventilation, sedation, and vasoactive agents.
  • Inhaled nitric oxide was universally used, with phosphodiesterase type 5 inhibitors being the most common additional vasodilator. Milrinone and epinephrine were frequent vasoactive infusions, while fentanyl and dexmedetomidine were preferred sedatives.

Conclusions:

  • Current management of acute pulmonary hypertensive crisis in critically ill children is highly variable across North American PICUs.
  • The findings underscore the absence of established North American guidelines and emphasize the need for further research to define best practices, standardize care, and improve patient outcomes.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
164
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
377
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
206
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
379
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
213
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
451